Fong et al. [70] observed that distinct inhibitors of PRMTs, such as PRMT5 selective inhibitor GSK3203591 and a pan-type I PRMTs inhibitor MS023, induce preferential killing of SF-mutated AML cells over wild-type control. This evidence concerns the gene PRMT5 and acute myeloid leukemia.